A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn’s Disease
Objective. We sought to investigate the efficacy and safety of Infliximab for prevention of postoperative recurrence in patients with Crohn’s disease (CD), in a meta-analysis of clinical trial results. Methods. The Medline, Embase, PubMed, and Web of Science databases were systematically searched fo...
Main Authors: | He Huang, Su Xu, Fubin Huang, Xia Wang, Yong Chen, Zhaoshan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/2615978 |
Similar Items
-
Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01) -
Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
by: A. V. Poletova, et al.
Published: (2020-10-01) -
Infliximab in Crohn's disease Infliximab en la enfermedad de Crohn
by: L. Rodrigo Sáez
Published: (2004-06-01) -
Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
by: Seong Yeon Jeong, et al.
Published: (2014-01-01) -
Infliximab in Crohn's disease
by: L. Rodrigo Sáez